Characterization of [3H]U46619 binding in pig aorta smooth muscle membranes. 1988

S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
Shionogi Research Laboratories, Shionogi and Co., Ltd., Osaka, Japan.

The binding characteristics of [3H]U46619, a tritiated thromboxane A2/prostaglandin H2 mimetic, were studied in pig aorta smooth muscle membranes. Binding was fast, saturable, selective and reversible. The KD values determined by kinetics, equilibrium binding and drug competition methods were 68, 42 and 53 nM, respectively. The Bmax was 87.8 fmol/mg protein. Specific binding was competitively displaced by thromboxane A2/prostaglandin H2 antagonists. Binding was also displaced by prostaglandins D2, E2 and F2 alpha with IC50 values of 8, 21 and 12 microM, respectively. U46619 contracted the rat and pig aorta smooth muscle, but the response of the latter was slower than that of the former. The antagonists prevented the U46619-induced contraction of rat aorta with the same rank order as that for the inhibition of ligand binding in pig aorta smooth muscle membranes. These results provide evidence that the putative thromboxane A2/prostaglandin H2 receptor in vascular smooth muscle membranes can be detected by a ligand binding technique.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011450 Prostaglandin Endoperoxides, Synthetic Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds. Prostaglandin Endoperoxide Analogs,Prostaglandin Endoperoxide Analogues,Synthetic Prostaglandin Endoperoxides,Analogues, Prostaglandin Endoperoxide,Endoperoxide Analogues, Prostaglandin,Endoperoxides, Synthetic Prostaglandin
D011463 Prostaglandins H A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001013 Aorta, Thoracic The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA. Aorta, Ascending,Aorta, Descending,Aortic Arch,Aortic Root,Arch of the Aorta,Descending Aorta,Sinotubular Junction,Ascending Aorta,Thoracic Aorta,Aortic Roots,Arch, Aortic,Ascending Aortas,Junction, Sinotubular,Root, Aortic,Sinotubular Junctions

Related Publications

S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
November 1987, Biochemical pharmacology,
S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
July 1984, Regulatory peptides,
S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
August 1982, European journal of pharmacology,
S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
September 1989, Canadian journal of physiology and pharmacology,
S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
August 1985, Biochemical pharmacology,
S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
May 1983, The Journal of pharmacology and experimental therapeutics,
S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
February 1993, The Biochemical journal,
S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
June 1985, British journal of pharmacology,
S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
January 1988, The American journal of physiology,
S Mihara, and M Doteuchi, and S Hara, and M Ueda, and M Ide, and M Fujimoto, and T Okabayashi
March 1984, Prostaglandins,
Copied contents to your clipboard!